Strong Trigger

now

Secures wide-scale distribution and specialty pharmacy contracts across the US immediately following the FDA approval of WHIM syndrome treatment 'Xolremdi'.

24h Trigger History

No history available

No trigger updates found for this ticker in the last 24 hours.